Objectives: EUHTA regulation has applied from the 1st January 2025 for oncology pr...
Read moreObjectives: To analyse how the mandatory EU Joint Clinical Assessment (JCA) could in...
Read moreFive success pillars — your JCA evidence-generation checklist From 12th January 2025, the Eu...
Read moreThe Joint Clinical Assessment (JCA), a core feature of the Regulation (EU) 2021/2282, aims to stream...
Read moreRemap Consulting presents ground-breaking insights and practical learnings from one of the pioneerin...
Read moreWe're delighted to announce our participation at ISPOR Europe 2024 in Barcelona this November. We'll...
Read moreWe examine whether the joint clinical assessment will expedite patient access and influence value pe...
Read moreOur latest article discusses key strategies for pharma manufacturers' commercial readiness for EU HT...
Read moreThe collaboration is aimed at enhancing HTA reports, facilitating resource and knowledge sharing and...
Read moreWe summarise the key discussions from HTAi 2024, with a focus on sustainability, networks and innova...
Read more